Co-Founder, President and Chief Scientific Officer
Levisonics
Levisonics manufactures non-contact blood coagulation devices that utilize photo-optical and viscoelastic measurements for real-time analysis of bleeding and thrombosis risk. Their technology enables drop-of-blood testing without sample contamination, providing reliable results for various healthcare applications outside traditional hospital settings.
- Hardware
- Healthcare Technology
- Medical Devices
Updated 23 months ago
Funding
Raised to date
$998.9KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current blood coagulation testing methods often require specialized equipment and trained personnel, limiting accessibility and delaying time-sensitive results, especially outside traditional hospital settings. Traditional methods may also involve larger blood draws, increasing the risk of complications, particularly in vulnerable populations.
Solution
Levisonics offers a point-of-care platform for comprehensive assessment of bleeding and thrombosis risk, utilizing non-contact blood coagulation devices. The technology employs photo-optical and viscoelastic measurements for real-time analysis, requiring only a drop of blood. Containerless processing eliminates surface contact during testing, preventing sample contamination and increasing reliability. The portable and compact benchtop design enables use outside traditional hospital settings, providing actionable results in real-time.
Target Audience
The primary target audience includes healthcare providers in pediatric hemostasis management, bleeding disorder management, anticoagulant therapy monitoring, transfusion guidance, and invasive procedures, as well as professionals in industrial quality control, pharmaceutical research & development, biomedical research, veterinary medicine, and small animal research.
Features
- Drop-of-blood analysis using both venous and capillary blood samples
- Integration of photo-optical and viscoelastic measurements for comprehensive coagulation and fibrinolysis assessment
- Containerless processing to prevent contact-induced sample contamination
- Real-time results for immediate clinical decision-making
- Portable and compact benchtop design for point-of-care testing
- Single test covering all stages of coagulation and fibrinolysis
- Nondetrimental acoustic forcing to prevent improper coagulation and fibrinolysis